Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, +170

Clinical Infectious Diseases

A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG)

Simona Sammassimo, Giancarlo Pruneri, Giovanna Andreola, +12

Hematological Oncology

A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy

Simona Bassi, Cristina Rabascio, Luca Nassi, +10

Transfusion and Apheresis Science

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunology +8

Hematological disorders after salvage <scp>PARPi</scp> treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes

Elisabetta Todisco, Federica Gigli, Chiara Ronchini, +13

International Journal of Cancer

Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia

Giuseppe Marotta, Monica Tozzi, Simona Sammassimo, +4

Hematology

Clinical presentation, diagnosis and management of therapy‐related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly‐ADP‐ribose polymerase inhibitors: A single‐center experience

Elisabetta Todisco, Federica Gigli, Mara Mantiero, +12

International Journal of Cancer

Epithelial Ovarian CancerCancer ManagementClinical PresentationGynecologyPathology +16

Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients

Paola Bertazzoni, Cristina Rabascio, Federica Gigli, +14

Leukemia & lymphoma/Leukemia and lymphoma

Hematological MalignancyLymphoid NeoplasiaOncologyChronic Lymphocytic LeukemiaSubcutaneous Cladribine +10

ecancermedicalscience

Angelo Gardellini, Federica Gigli, Ana Babić, +5

ecancermedicalscience

Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant

Francesco Spina, Vittorio Montefusco, Claudia Crippa, +12

Leukemia & lymphoma/Leukemia and lymphoma

Hematological MalignancyAllogeneic TransplantTransplantationOncologyHealth Sciences +13

Bortezomib, cyclophosphamide, dexamethasone <i>versus</i> lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Vittorio Montefusco, Alessandro Corso, Mónica Galli, +13

British Journal of Haematology